All lobbying filings

AGILON HEALTH, INC.

AGILON HEALTH, INC. filed a Q1 report for AGILON HEALTH, INC. on April 20, 2026.

Lobbying for AGILON HEALTH, INC. · Health care provider

All filings by AGILON HEALTH, INC. · Everything AGILON HEALTH, INC. has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Expenses

$150,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Texas

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Issues related to value-based health care, including Medicare Advantage (MA) and ACO models; Medicare Shared Savings Program (MSSP) and SCO REACH Model; LEAD Model; MA data sharing; physician reimbursement and Medicare and CHIP Reauthorization Act (MACRA)-related policies (PL 114-10), including APM bonus payments; Consolidated Appropriations Act, 2026 (PL 119-75); HR.8129, To amend title XVIII of the Social Security Act to establish a full risk ACO program, full-risk legislation; and related CMS innovation and payment model activities through CMMI.

Bills named in this filing 1

H.R. 8129
To amend title XVIII of the Social Security Act to establish a full risk ACO program.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.